US2008286301A1PendingUtilityA1
Treatment of diabetes
Est. expiryMay 12, 2014(expired)· nominal 20-yr term from priority
Inventors:John Dupre
A61P 3/08A61P 3/04A61K 38/28A61P 3/10A61K 38/26
53
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Insulin-requiring diabetes in a mammal can be treated by a process comprising administering to the mammal in a suitable regimen an effective amount of insulin and an effective amount of a peptide comprising a peptide selected from the group consisting of (a) glucagon-like peptide 1(7-37); (b) glucagon-like peptide 1(7-36)amide; and (c) an effective fragment or analogue of (a) or (b).
Claims
exact text as granted — not AI-modified1 - 14 . (canceled)
16 . A method of treating Type I diabetes in a mammal comprising administering to the mammal in a suitable regimen an effective amount of a peptide selected from the group consisting of:
(a) glucagon-like peptide 1(7-37); and (b) glucagon-like peptide 1(7-36) amide wherein the mammal is in the remission phase of Type I diabetes.
24 . A composition for the treatment of insulin requiring diabetes comprising one or more of:
(a) glucagon-like peptide 1(7-37) (b) glucagon-like peptide 1(7-36) amide; and (c) an agonist analogue of (a) or (b).Join the waitlist — get patent alerts
Track US2008286301A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.